1 - 5 out of 5Page size: 10
  1. 2018

  2. Epigenetic and pharmacological targeting of neuroinflammation as novel therapeutic interventions for epilepsy

    Iori, V., 2018, 232 p.

    Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  3. miR147b: A novel key regulator of interleukin 1 beta-mediated inflammation in human astrocytes

    van Scheppingen, J., Mills, J. D., Zimmer, T. S., Broekaart, D. W. M., Iori, V., Bongaarts, A., Anink, J. J., Iyer, A. M., Korotkov, A., Jansen, F. E., van Hecke, W., Spliet, W. G., van Rijen, P. C., Baayen, J. C., Vezzani, A., van Vliet, E. A. & Aronica, E., 2018, In: Glia. 66, 5, p. 1082-1097

    Research output: Contribution to journal › Article › Academic › peer-review

  4. 2017

  5. Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy

    Iori, V., Iyer, A. M., Ravizza, T., Beltrame, L., Paracchini, L., Marchini, S., Cerovic, M., Hill, C., Ferrari, M., Zucchetti, M., Molteni, M., Rossetti, C., Brambilla, R., Steve White, H., D'Incalci, M., Aronica, E. & Vezzani, A., 2017, In: Neurobiology of disease. 99, p. 12-23

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Epigenetic control of epileptogenesis by miR-146a

    Iori, V., Aronica, E. & Vezzani, A., 2017, In: Oncotarget. 8, 28, p. 45040-45041 2 p.

    Research output: Contribution to journal › Editorial › Academic › peer-review

  7. 2013

  8. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures

    Iori, V., Maroso, M., Rizzi, M., Iyer, A. M., Vertemara, R., Carli, M., Agresti, A., Antonelli, A., Bianchi, M. E., Aronica, E., Ravizza, T. & Vezzani, A., 2013, In: Neurobiology of disease. 58, p. 102-114

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 111688